Barclays’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-200
Closed -$9K – 6606
2017
Q1
$9K Hold
200
– – ﹤0.01% 6097
2016
Q4
$7K Buy
+200
New +$7.76K ﹤0.01% 6010

Other funds holding ACHC

Barclays's ACHC Position: Q3 2026 in Review

Barclays reduced its Acadia Healthcare (ACHC) stake by 89% in Q3 2026, selling an estimated $22.1M and leaving 86,467 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

Barclays first reported a position in ACHC in Q2 2013 and has held it in 54 quarters since. The position peaked at $46.4M in Q2 2024. 211 funds tracked by Wall St. Rank hold ACHC as of Q3 2026.

  • Barclays held 86,467 shares of Acadia Healthcare worth $2.38M as of Q3 2026.
  • Barclays sold 734,873 Acadia Healthcare shares in Q3 2026, an estimated $22.1M.
  • Acadia Healthcare made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2478 holding.
  • Barclays first reported a position in Acadia Healthcare in Q2 2013 and has held it in 54 quarters since.
  • Barclays's Acadia Healthcare position peaked at $46.4M in Q2 2024.
  • 211 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.